United States · FDA National Drug Code directory

Low Hepatitis Nosode 4026

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63083-4026_d63d3e79-bf87-491e-a7c0-3976f1734a37
Product NDC: 63083-4026
Form: LIQUID
Composition / generic term: Low Hepatitis Nosode
Labeler: Professional Complementary Health Formulas
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19840815
Source listing expiry: 20271231

Source-listed ingredients

HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) — 16 [hp_X]/59mL
HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN — 16 [hp_X]/59mL
HEPATITIS C IMMUNE GLOBULIN (HUMAN) — 16 [hp_X]/59mL

These values do not establish equivalence or a dose recommendation.

Packages

59 mL in 1 BOTTLE, DROPPER (63083-4026-2) · 63083-4026-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →